Stock Market & Financial Investment News

News Breaks February 7, 2013 12:02 EDT MRK, MYL Merck win over Mylan related to Zetia, Vytorin patents upheld on appeal The U.S. Court of Appeals for the Federal Circuit affirmed a lower court ruling in Merck's (MRK) favor in two jointly related patent infringement suits against Mylan Pharmaceuticals (MYL). The lower court previously found that Merck's patent which covers ezetimibe, an active ingredient in both Zetia and Vytorin, was valid and enforceable. The lower court also issued an injunction blocking the approval of Mylan's generic versions until the expiration of Merck's patent. Reference Link News For MRK;MYL From The Last 14 Days Check below for free stories on MRK;MYL the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. 1 | 2 | all recent news | >> May 21, 2013 18:56 EDT MRK On The Fly: After Hours Movers Subscribe for More Information 17:03 EDT MRK Merck announces $5B share repurchase Subscribe for More Information 17:01 EDT MRK Merck announces $5B accelerated share repurchase Subscribe for More Information 07:44 EDT MRK Sachs Associates to host a forum Subscribe for More Information 07:35 EDT MYL Mylan: Appellate Court rules in favor of company in patent infringement case Subscribe for More Information May 20, 2013 17:49 EDT MRK Merck sleep drug effective, dosages questioned, WSJ reports Subscribe for More Information 11:27 EDT MYL Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva Subscribe for More Information 07:32 EDT MRK Society for Information Display / IHS to host a conference Display Week 2013 is being held in Vancouver, British Columbia on May 19-24. May 17, 2013 14:48 EDT MYL Actavis may bid for Warner Chilcott to ward off takeover, Reuters says Subscribe for More Information 13:56 EDT MYL Actavis may purchase Warner Chilcott as takeover defense, Reuters reports Over past few weeks, Actavis (ACT) has "spurned approaches" from Valeant (VRX) and Mylan (MYL), and has instead pursued a bid for Warner Chilcott (WCRX), according to Reuters, citing people familiar with the situation. 07:31 EDT MYL Mylan launches generic Tricor tablets Subscribe for More Information May 16, 2013 08:55 EDT MRK BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call Subscribe for More Information May 15, 2013 19:37 EDT MYL Novartis weighing Actavis bid, WSJ reports Subscribe for More Information 17:36 EDT MYL Paulson gives quarterly update on stakes Subscribe for More Information 11:42 EDT MYL Mylan launches generic Zomig tablets Subscribe for More Information 07:03 EDT MYL Mylan highly unlikely to acquire Actavis, says Barclays Subscribe for More Information May 14, 2013 17:39 EDT MRK Moody's lowers Merck's guaranteed debt to A1 from Aa3; stable outlook Moody's Investors Service lowered the long-term ratings of Merck by one notch, including the guaranteed senior unsecured rating to A1 from Aa3 and the non-guaranteed senior unsecured rating to A2 from A1. This action concludes a review for downgrade initiated on May 1, 2013. At the same time, Moody's affirmed Merck's Prime-1 commercial paper rating. The rating outlook is stable. 13:55 EDT MYL Actavis weighing over $5B bid for Warner Chilcott, snubbed Mylan, Bloomberg says Subscribe for More Information 13:22 EDT MYL Actavis turned down $15B takeover bid from Mylan, Bloomberg reports Subscribe for More Information May 10, 2013 11:48 EDT MRK Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information 1 | 2 | all recent news | >> Sign up for a free trial to see the rest of the stories you've been missing.